Transdifferentiation of lymphoma into sarcoma associated with profound reprogramming of the epigenome.

Autor: Zhang Q; Department of Pathology, University of Pennsylvania, Philadelphia, PA., Orlando EJ; Novartis Institute for Biomedical Research, Cambridge, MA., Wang HY; Department of Pathology, University of Pennsylvania, Philadelphia, PA., Bogusz AM; Department of Pathology, University of Pennsylvania, Philadelphia, PA., Liu X; Department of Pathology, University of Pennsylvania, Philadelphia, PA., Lacey SF; Fox Chase Cancer Center, Philadelphia, PA; and., Strauser HT; Department of Pathology, University of Pennsylvania, Philadelphia, PA., Nunez-Cruz S; Department of Pathology, University of Pennsylvania, Philadelphia, PA., Nejati R; Fox Chase Cancer Center, Philadelphia, PA; and., Zhang P; Department of Pathology, University of Pennsylvania, Philadelphia, PA., Brooks S; Department of Pathology, University of Pennsylvania, Philadelphia, PA., Watt C; Department of Pathology, University of Pennsylvania, Philadelphia, PA., Melenhorst JJ; Center for Cellular Immunotherapies and., June CH; Department of Pathology, University of Pennsylvania, Philadelphia, PA.; Center for Cellular Immunotherapies and., Schuster SJ; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Wasik MA; Department of Pathology, University of Pennsylvania, Philadelphia, PA.; Fox Chase Cancer Center, Philadelphia, PA; and.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.
Jazyk: angličtina
Zdroj: Blood [Blood] 2020 Oct 22; Vol. 136 (17), pp. 1980-1983.
DOI: 10.1182/blood.2020005123
Databáze: MEDLINE